Dr Reddys Laboratories (RDY) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to $247.76.
- Dr Reddys Laboratories' EPS (Basic) fell 1453.92% to $247.76 in Q4 2025 from the same period last year, while for Dec 2025 it was $247.76, marking a year-over-year decrease of 1453.92%. This contributed to the annual value of $0.79 for FY2025, which is 8034.83% down from last year.
- According to the latest figures from Q4 2025, Dr Reddys Laboratories' EPS (Basic) is $247.76, which was down 1453.92% from $289.91 recorded in Q4 2024.
- Dr Reddys Laboratories' EPS (Basic)'s 5-year high stood at $394.87 during Q3 2024, with a 5-year trough of $0.0 in Q3 2022.
- In the last 5 years, Dr Reddys Laboratories' EPS (Basic) had a median value of $63.57 in 2021 and averaged $125.78.
- In the last 5 years, Dr Reddys Laboratories' EPS (Basic) tumbled by 9999.99% in 2022 and then surged by 9763239066.52% in 2023.
- Dr Reddys Laboratories' EPS (Basic) (Quarter) stood at $6.02 in 2021, then crashed by 90.92% to $0.55 in 2022, then soared by 49131.01% to $269.16 in 2023, then increased by 7.71% to $289.91 in 2024, then fell by 14.54% to $247.76 in 2025.
- Its EPS (Basic) was $247.76 in Q4 2025, compared to $289.91 in Q4 2024 and $394.87 in Q3 2024.